Cavopulmonary assist: Long-term reversal of the Fontan paradox.

Abstract

OBJECTIVE\nFontan circulatory inefficiency can be addressed by replacing the missing subpulmonary power source to reverse the Fontan paradox. An implantable cavopulmonary assist device is described that will simultaneously reduce systemic venous pressure and increase pulmonary arterial pressure, improving preload and cardiac output, in a univentricular Fontan circulation on a long-term basis.\n\n\nMETHODS\nA rotary blood pump that was based on the von Karman viscous pump was designed for implantation into the total cavopulmonary connection (TCPC). It will impart modest pressure energy to augment Fontan flow without risk of obstruction. In the event of rotational failure, it is designed to default to a passive flow diverter. Pressure-flow performance was characterized in\xa0vitro in a Fontan mock circulatory loop with blood analog.\n\n\nRESULTS\nThe pump performed through the fully specified operating range, augmenting flow in all 4 directions of the TCPC. Pressure rise of 6 to 8\xa0mm Hg was readily achieved, ranging to 14\xa0mm Hg at highest speed (5600\xa0rpm). Performance was consistent across a wide range of cardiac outputs. In stalled condition (0\xa0rpm), there was no discernible pressure loss across the TCPC.\n\n\nCONCLUSIONS\nA blood pump technology is described that can reverse the Fontan paradox and may permit a surgical strategy of long-term biventricular maintenance of a univentricular Fontan circulation. The technology is intended for Fontan failure in which right-sided circulatory inefficiencies predominate and ventricular systolic function is preserved. It may also apply before clinical Fontan failure as health maintenance to preempt the progression of Fontan disease.